Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
769 4 |
Ultima descărcare din IBN: 2020-04-15 19:38 |
Căutarea după subiecte similare conform CZU |
616.24-002.5:[616.36-002+616.98:578.828(HIV)] (1) |
Patologia sistemului respirator. Tulburări ale organelor de respiraţie (757) |
Patologia sistemului digestiv. Tulburări ale tubului alimentar (1732) |
Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (585) |
Virologie (442) |
SM ISO690:2012 SPÎNU, Constantin, ISAC, Maria, GURIEV, Vladimir, SAJIN, Octavian, SPÎNU, Igor. Studierea şi evaluarea markerilor serologici ai hepatitelor virale B, C şi HIV/SIDA la bolnavii de tuberculoză. In: Sănătate Publică, Economie şi Management în Medicină , 2016, nr. 1(65), pp. 27-31. ISSN 1729-8687. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Sănătate Publică, Economie şi Management în Medicină | ||||||
Numărul 1(65) / 2016 / ISSN 1729-8687 /ISSNe 2587-3873 | ||||||
|
||||||
CZU: 616.24-002.5:[616.36-002+616.98:578.828(HIV)] | ||||||
Pag. 27-31 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
In the article “Study and evaluation of serological markers of viral hepatitis B, C and HIV / AIDS in TB patients” were presented data on the level of detection of markers of viral hepatitis B, C and HIV/AIDS among TB patients. In total in the study were included 110 patients with tuberculosis. Following the investigation it was established that the marker HBs Ag was detected in 16.4 ± 3.5% (18 people), anti-HBc were detected in 55.5 ± 4.7% (61 people), protective antibodies against hepatitis B–anti-HBs were detected in 61.8 ± 4.6% (68 persons), where as antibodies to hepatitis C virus were detected in 8.1 ± 2.6% (9 people). Proportion of HIV positive Ab/Ag was 4.5 ± 2.0% (5 people).The results confirm that TB patients are at increased risk of infection with viral hepatitis B, C and HIV infection and need to be vaccinated against hepatitis B. |
||||||
Cuvinte-cheie viral hepatitis B, C, HIV/AIDS, markers, level of infection |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-55774</cfResPublId> <cfResPublDate>2016-02-29</cfResPublDate> <cfVol>65</cfVol> <cfIssue>1</cfIssue> <cfStartPage>27</cfStartPage> <cfISSN>1729-8687</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/55774</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Studierea şi evaluarea markerilor serologici ai hepatitelor virale B, C şi HIV/SIDA la bolnavii de tuberculoză</cfTitle> <cfKeyw cfLangCode='RO' cfTrans='o'>viral hepatitis B; C; HIV/AIDS; markers; level of infection</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p><em>In the article “Study and evaluation of serological markers of viral hepatitis B, C and HIV / AIDS in TB patients” were presented data on the level of detection of markers of viral hepatitis B, C and HIV/AIDS among TB patients. In total in the study were included 110 patients with tuberculosis. Following the investigation it was established that the marker HBs Ag was detected in 16.4 ± 3.5% (18 people), anti-HBc were detected in 55.5 ± 4.7% (61 people), protective antibodies against hepatitis B–anti-HBs were detected in 61.8 ± 4.6% (68 persons), where as antibodies to hepatitis C virus were detected in 8.1 ± 2.6% (9 people). Proportion of HIV positive Ab/Ag was 4.5 ± 2.0% (5 people).The results confirm that TB patients are at increased risk of infection with viral hepatitis B, C and HIV infection and need to be vaccinated against hepatitis B.</em> </p></cfAbstr> <cfAbstr cfLangCode='RU' cfTrans='o'><p><em>В статье “Изучение и оценка серологических исследований на маркеры вирусных гепатитов В, С и ВИЧ-инфекции среди пациентов больных туберкулёзом” представлены данные по уровню выявления маркеров гепатитов В, С и ВИЧ/СПИД среди больных туберкулезом. Всего было обследовано 110 больных туберкулезом. В результате исследования было установлено, что маркер </em><em>Hbs</em><em> </em><em>Ag</em><em> был обнаружен у 16,4 ± 3,5% (18 человек), анти-</em><em>HB</em><em> </em><em>c</em><em>сумар был обнаружен у 55,5 ± 4,7% (61 человек), анти-</em><em>HBs</em><em> были обнаружены в 61,8 ± 4,6% (68 человек), в то время как антитела к вирусу гепатита С были обнаружены в 8,1 ± 2,6% (9 человек). Доля положительных на ВИЧ </em><em>Ag</em><em>/</em><em>Ab</em><em> составила 4,5 ±2,0% случаев (5 человек). Полученные результаты подтверждают, что больные туберкулёзом относятся к группам повышенного риска инфицирования вирусными гепатитами </em><em>B</em><em>, С и ВИЧинфекции, которые нуждаются в вакцинации против гепатита В.</em></p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-11789</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-11300</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-32620</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-26482</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-13425</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-11789</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11789-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> <cfFamilyNames>Spînu</cfFamilyNames> <cfFirstNames>Constantin</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-11300</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11300-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> <cfFamilyNames>Isac</cfFamilyNames> <cfFirstNames>Maria</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-32620</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-32620-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> <cfFamilyNames>Guriev</cfFamilyNames> <cfFirstNames>Vladimir</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-26482</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-26482-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> <cfFamilyNames>Sajin</cfFamilyNames> <cfFirstNames>Octavian</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-13425</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-13425-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2016-02-29T24:00:00</cfStartDate> <cfFamilyNames>Spînu</cfFamilyNames> <cfFirstNames>Igor</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>